Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Natus Medical, Inc. (NASDAQ: BABY).

Full DD Report for BABY

You must become a subscriber to view this report.


Recent News from (NASDAQ: BABY)

Report: Developing Opportunities within Natus Medical, Aptevo Therapeutics, Revlon, Silgan, Resources Connection, and TrustCo Bank Corp NY - Future Expectations, Projections Moving into 2018
NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Natus Medical Incorporated (NASDAQ:BABY), Aptevo Therapeutics Inc. (NASD...
Source: GlobeNewswire
Date: April, 30 2018 07:50
Natus Medical's (BABY) CEO Jim Hawkins on Q1 2018 Results - Earnings Call Transcript
Natus Medical Inc. (BABY) Q1 2018 Earnings Conference Call April 25, 2018 11:00 ET Executives Jim Hawkins - President & CEO Jonathan Kennedy - EVP & CFO Analysts Raymond Myers - Benchmark Brian Weinstein - William Blair Jayson Bedford - Raymond James David Solom...
Source: SeekingAlpha
Date: April, 25 2018 16:42
Natus Medical EPS in-line, beats on revenue
Natus Medical (NASDAQ: BABY ): Q1 EPS of $0.24 in-line. More news on: Natus Medical Incorporated, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: April, 25 2018 06:06
Natus Medical Announces First Quarter Financial Results
Reports record first quarter revenue of $128.6 million Reports first quarter GAAP loss per share of $0.10 and non-GAAP earnings per share of $0.24 PLEASANTON, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced financial results for...
Source: GlobeNewswire
Date: April, 25 2018 06:05
Natus Confirms Receipt of Notice of Voce Capital's Intent to Nominate Director Candidates to Replace 50% of the Natus Board
PLEASANTON, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated   (NASDAQ:BABY) (“Natus” or the “Company”) today confirmed that Voce Capital Management LLC (“Voce”), which has indicated that it owns approximately 2.0% of the C...
Source: GlobeNewswire
Date: April, 23 2018 16:11
Natus Medical to Hold 2018 First Quarter Financial Results Conference Call on April 25th
PLEASANTON, Calif., April 11, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will release its 2018 first quarter financial results before the market opens on Wednesday, April 25 th . Natus management will host an investment-community con...
Source: GlobeNewswire
Date: April, 11 2018 07:00
Is Natus Medical Inc. Stocks Overbought?
Natus Medical Inc. (Nasdaq:BABY) shares have climbed today, but that may not actually be good news for the healthcare company as its RSI is over 70 – putting it into ‘overbought’ territory. Located in Pleasanton, California, Natus Medical Inc. is a provider of ...
Source: MicroSmallCap
Date: March, 22 2018 19:28
New Research Coverage Highlights Real Goods Solar, LivePerson, Manhattan Associates, Natus Medical, BioScrip, and FBL Financial Group -- Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Real Goods Solar, Inc. (NASDAQ:RGSE), LivePerson, Inc. (NASDAQ:LPSN), Ma...
Source: GlobeNewswire
Date: March, 21 2018 08:20
Natus to Present at 30th Annual Roth Conference
PLEASANTON, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer will present and Jonathan Kennedy, Executive Vice-President and Chief Financial Officer will be in attendance at the 30th...
Source: GlobeNewswire
Date: March, 05 2018 07:00
Key events next week - healthcare
Noteworthy events for the week of March 4 - 10 for healthcare investors: More news on: Merck & Co Inc., Arena Pharmaceuticals, Inc., NeuroMetrix, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: March, 02 2018 11:03

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-1435.4037.2537.9035.40429,957
2018-08-1335.3035.3535.7535.1597,121
2018-08-1035.7535.5036.3035.45138,757
2018-08-0935.4035.9036.1035.05180,483
2018-08-0836.0035.3036.2535.15224,252

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1475,880149,76950.6647Short
2018-08-1317,87824,30973.5448Short
2018-08-1023,38832,38172.2275Short
2018-08-099,69437,69325.7183Cover
2018-08-0826,96156,17947.9912Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BABY.


About Natus Medical, Inc. (NASDAQ: BABY)

Logo for Natus Medical, Inc. (NASDAQ: BABY)

Not available

 

Contact Information

 

 

Current Management

  • Tim C. Johnson / CEO, President, COO, Secretary
  • William H. Lawrenson / CFO

Current Share Structure

  • Market Cap: $1,170,563,108 - 05/14/2018
  • Issue and Outstanding: 33,160,428 - 02/21/2018

 


Recent Filings from (NASDAQ: BABY)

Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: May, 17 2018
Non-management revised preliminary proxy soliciting materials
Filing Type: PRRN14AFiling Source: edgar
Filing Date: May, 15 2018
Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: May, 11 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Preliminary proxy statement containing contested solicitations
Filing Type: PREC14AFiling Source: edgar
Filing Date: May, 07 2018
Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: May, 04 2018
Preliminary proxy statement containing contested solicitations
Filing Type: PREC14AFiling Source: edgar
Filing Date: May, 02 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Additional proxy soliciting materials filed by non-management
Filing Type: DFAN14AFiling Source: edgar
Filing Date: April, 23 2018

 

 


Daily Technical Chart for (NASDAQ: BABY)

Daily Technical Chart for (NASDAQ: BABY)


Stay tuned for daily updates and more on (NASDAQ: BABY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: BABY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BABY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of BABY and does not buy, sell, or trade any shares of BABY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/